NEWSROOM

AB INTL GROUP Announces Repurchase of Common Stock for Cancelation

AB INTL GROUP Announces Repurchase of Common Stock for Cancelation

NEW YORK, Aug. 26, 2024 - AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, today announced a repurchase of 50,296,980 shares of common stock for cancelation. Its positive cash flow continues to come from net profitability to enable the repurchase of more shares in the near future. On August 21, 2024, AB International Group Corp. (the “Company”) entered into Repurchase Agreements with seven shareholders, all non-affiliates of the...

read more
Halberd Corp. Issues Letter to Shareholders

Halberd Corp. Issues Letter to Shareholders

JACKSON CENTER, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) today issued the following letter to its shareholders: Halberd Corp. - Taking a Moment to Recenter Our Technical Progress Introducing Tri-ax™ TBI Nasal Spray Treatment- the DoD selected our MSU-led pre-proposal, inviting us to submit a full application/proposal This is the first of a series of three significant Press Releases we plan to issue shortly. Many of our investors have been voicing...

read more
ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility

ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility

Successful Conversion Eliminates Over $4 Million in Long-Term Debt New York, NY, August 26, 2024 - ANEW MEDICAL, INC. (NASDAQ: WENA), a leading U.S. biotechnology company pioneering cell and gene-based treatments for aging and age-related diseases, announces the successful conversion of its convertible promissory notes by investors. This strategic move significantly strengthens ANEW’s balance sheet by eliminating over $4 million in long-term debt. The elimination of over $4 million in...

read more
Biofuels Brazil Forum 2024

Biofuels Brazil Forum 2024

Biofuels Brazil Forum 2024 Date: 27-28 November 2024, Sao Paulo, BrazilOrganizer: Vostock CapitalWebsite "Biofuels Brazil International Investment Forum" is the premier platform for biofuel producers, regulatory bodies, government officials, technology pioneers, equipment suppliers, EPC, engineering companies, and investors from Brazil, Latin America, and Europe. It fosters strategic partnerships and innovation in the biofuels sector, advancing Brazil's leadership in sustainable development...

read more
Foro Biocombustibles Brasil 2024

Foro Biocombustibles Brasil 2024

Foro Biocombustibles Brasil 2024 Fecha: 27-28 de noviembre de 2024, São Paulo, BrasilOrganizador: Vostock CapitalWebsite El "Foro Internacional de Inversiones en Biocombustibles de Brasil" es la plataforma principal para productores de biocombustibles, organismos reguladores, funcionarios gubernamentales, pioneros tecnológicos, proveedores de equipos, empresas de EPC y de ingeniería, e inversores de Brasil, América Latina y Europa. Fomenta alianzas estratégicas e innovación en el sector de los...

read more
Fórum de Biocombustíveis Brasil 2024

Fórum de Biocombustíveis Brasil 2024

Fórum de Biocombustíveis Brasil 2024 Data: 27-28 de novembro de 2024, São Paulo, Brasil  Organizador: Vostock Capital  Website O "Fórum Internacional de Investimentos em Biocombustíveis Brasil" é a principal plataforma para produtores de biocombustíveis, órgãos reguladores, autoridades governamentais, pioneiros em tecnologia, fornecedores de equipamentos, empresas de EPC e engenharia, e investidores do Brasil, América Latina e de outras regiões. O evento promove parcerias...

read more
“Mining Chile and Latin America 2024” in Santiago de Chile

“Mining Chile and Latin America 2024” in Santiago de Chile

“Mining Chile and Latin America 2024” in Santiago de Chile Meet industry leaders and learn the best practices for the mining sector. Date: October 1st and 2nd   2024 Place: Santiago de Chile Organizer: Vostock Capital Website 5th International Congress and Exhibition Mining Chile and Latin America 2024 brings together, during two days,  + 200 decision-makers from national and international companies, + 40 Mining Projects in Chile technology and service providers, and international...

read more
Congreso Internacional y Exhibición “Minería Chile y América Latina 2024″

Congreso Internacional y Exhibición “Minería Chile y América Latina 2024″

Congreso Internacional y Exhibición “Minería Chile y América Latina 2024" Fecha: 1 y 2 de octubre 2024 Lugar: Santiago de Chile Organizador: Vostock Capital Sitio Web El 5º Congreso y Exhibición Internacional Minería Chile y América Latina 2024 reúne a más de 200 ejecutivos con poder de decisión de empresas nacionales e internacionales, más de 40 proyectos de Mineria en America latina, proveedores de tecnología y servicios, inversionistas internacionales y locales para discutir las principales...

read more
Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research

Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research

Affecting about 6 million Americans, OLP is a chronic inflammatory disease affecting the mucous membranes of the mouth No FDA-approved therapy currently exists for OLP Patient registry and OLP study information is now available Pittsburgh, PA, August 22, 2024 – Lipella Pharmaceuticals, Inc. (NASDAQ: LIPO) has launched an Oral Lichen Planus (OLP) Patient Registry. This online platform is designed to enhance research and drive the development of new treatments for OLP, a chronic inflammatory...

read more
BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Study Evaluating the Value of Vendaje® Compared to the Standard of Care for Non-Healing Diabetic Foot Ulcers

BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Study Evaluating the Value of Vendaje® Compared to the Standard of Care for Non-Healing Diabetic Foot Ulcers

Study supports BioStem’s strategic growth initiatives and accelerates product adoption by providing data to healthcare professionals and payers on the benefits of Vendaje POMPANO BEACH, FL, August 21, 2024 - BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces that the Institutional Review Board (IRB) has approved a clinical study to evaluate Vendaje® for...

read more

Contact Us

PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850